company background image
RICH

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo RtBUSE:RICHTER Stock Report

Market Cap

Ft1.6t

7D

-1.4%

1Y

26.6%

Updated

18 Oct, 2021

Data

Company Financials +
RICHTER fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance5/6
Financial Health6/6
Dividends4/6

RICHTER Overview

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Competitors

Viatris

NasdaqGS:VTRS

US$16.3b

Teva Pharmaceutical Industries

NYSE:TEVA

US$10.7b

Bausch Health Companies

NYSE:BHC

US$10.2b

Hikma Pharmaceuticals

LSE:HIK

UK£5.4b

Price History & Performance

Summary of all time highs, changes and price drops for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Historical stock prices
Current Share PriceFt8,525.00
52 Week HighFt6,280.00
52 Week LowFt9,320.00
Beta0.41
1 Month Change-2.63%
3 Month Change3.65%
1 Year Change26.58%
3 Year Change59.35%
5 Year Change41.14%
Change since IPO4,636.11%

Recent News & Updates

Sep 01
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s (BUSE:RICHTER) Intrinsic Value Is Potentially 99% Above Its Share Price

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s (BUSE:RICHTER) Intrinsic Value Is Potentially 99% Above Its Share Price

How far off is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. ( BUSE:RICHTER ) from its intrinsic value? Using...

Aug 11
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Has A Pretty Healthy Balance Sheet

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Has A Pretty Healthy Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

May 13
Analyst Estimates: Here's What Brokers Think Of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) After Its First-Quarter Report

Analyst Estimates: Here's What Brokers Think Of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) After Its First-Quarter Report

Last week, you might have seen that Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. ( BUSE:RICHTER ) released its...

Shareholder Returns

RICHTERHU PharmaceuticalsHU Market
7D-1.4%0.9%1.6%
1Y26.6%13.6%65.5%

Return vs Industry: RICHTER exceeded the Hungarian Pharmaceuticals industry which returned 13.6% over the past year.

Return vs Market: RICHTER underperformed the Hungarian Market which returned 65.5% over the past year.

Price Volatility

Is RICHTER's price volatile compared to industry and market?
RICHTER volatility
RICHTER Beta0.41
Industry Beta0.44
Market Beta1

Stable Share Price: RICHTER is not significantly more volatile than the rest of Hungarian stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: RICHTER's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
190112,665Gábor Orbánhttps://www.richter.hu

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Fundamentals Summary

How do Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's earnings and revenue compare to its market cap?
RICHTER fundamental statistics
Market CapFt1.58t
Earnings (TTM)Ft99.07b
Revenue (TTM)Ft584.89b

16.0x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RICHTER income statement (TTM)
RevenueFt584.89b
Cost of RevenueFt259.29b
Gross ProfitFt325.60b
ExpensesFt226.54b
EarningsFt99.07b

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Nov 08, 2021

Earnings per share (EPS)533.66
Gross Margin55.67%
Net Profit Margin16.94%
Debt/Equity Ratio1.2%

How did RICHTER perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

42%

Payout Ratio

Valuation

Is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: RICHTER (HUF8525) is trading below our estimate of fair value (HUF18219.26)

Significantly Below Fair Value: RICHTER is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: RICHTER is good value based on its PE Ratio (16x) compared to the European Pharmaceuticals industry average (26.2x).

PE vs Market: RICHTER is poor value based on its PE Ratio (16x) compared to the Hungarian market (15.4x).


Price to Earnings Growth Ratio

PEG Ratio: RICHTER is good value based on its PEG Ratio (0.8x)


Price to Book Ratio

PB vs Industry: RICHTER is good value based on its PB Ratio (1.9x) compared to the XE Pharmaceuticals industry average (3.4x).


Future Growth

How is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

20.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: RICHTER's forecast earnings growth (20.1% per year) is above the savings rate (1.2%).

Earnings vs Market: RICHTER's earnings (20.1% per year) are forecast to grow faster than the Hungarian market (4.9% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: RICHTER's revenue (7.9% per year) is forecast to grow faster than the Hungarian market (6.5% per year).

High Growth Revenue: RICHTER's revenue (7.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: RICHTER's Return on Equity is forecast to be low in 3 years time (13.9%).


Past Performance

How has Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt performed over the past 5 years?

15.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: RICHTER has high quality earnings.

Growing Profit Margin: RICHTER's current net profit margins (16.9%) are higher than last year (12.5%).


Past Earnings Growth Analysis

Earnings Trend: RICHTER's earnings have grown by 15.1% per year over the past 5 years.

Accelerating Growth: RICHTER's earnings growth over the past year (45.4%) exceeds its 5-year average (15.1% per year).

Earnings vs Industry: RICHTER earnings growth over the past year (45.4%) exceeded the Pharmaceuticals industry 10.2%.


Return on Equity

High ROE: RICHTER's Return on Equity (12.1%) is considered low.


Financial Health

How is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's financial position?


Financial Position Analysis

Short Term Liabilities: RICHTER's short term assets (HUF369.0B) exceed its short term liabilities (HUF117.1B).

Long Term Liabilities: RICHTER's short term assets (HUF369.0B) exceed its long term liabilities (HUF96.7B).


Debt to Equity History and Analysis

Debt Level: RICHTER's debt to equity ratio (1.2%) is considered satisfactory.

Reducing Debt: RICHTER's debt to equity ratio has reduced from 6.4% to 1.2% over the past 5 years.

Debt Coverage: RICHTER's debt is well covered by operating cash flow (1197.3%).

Interest Coverage: RICHTER earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt current dividend yield, its reliability and sustainability?

2.64%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: RICHTER's dividend (2.64%) is higher than the bottom 25% of dividend payers in the Hungarian market (1.51%).

High Dividend: RICHTER's dividend (2.64%) is low compared to the top 25% of dividend payers in the Hungarian market (4.38%).


Stability and Growth of Payments

Stable Dividend: RICHTER's dividend payments have been volatile in the past 10 years.

Growing Dividend: RICHTER's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (42.3%), RICHTER's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: RICHTER's dividends in 3 years are forecast to be well covered by earnings (37.7% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.5yrs

Average board tenure


CEO

Gábor Orbán (42 yo)

3.92yrs

Tenure

Mr. Gábor Orbán has been Chief Executive Officer of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. since November 1, 2017 and Member of Executive Board since September 05, 2016. Mr. Orbán served as...


Board Members

Experienced Board: RICHTER's board of directors are considered experienced (4.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s employee growth, exchange listings and data sources


Key Information

  • Name: Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
  • Ticker: RICHTER
  • Exchange: BUSE
  • Founded: 1901
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: Ft1.583t
  • Shares outstanding: 185.64m
  • Website: https://www.richter.hu

Number of Employees


Location

  • Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
  • GyOemroi Ut 19-21.
  • Budapest
  • 1103
  • Hungary

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/18 21:36
End of Day Share Price2021/10/18 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.